A white matter disorder in dementia of the Alzheimer type: A pathoanatomical study
The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Abstract
In cases of Alzheimer's presenile and senile dementia, Alzheimer's disease (AD) and senile dementia of the Alzheimer type (SDAT), respectively, we have observed, in addition to the gray matter degeneration, a lesion that has the character of an incomplete infarction confined to the white matter. It is encountered in 60% of both groups, with mild changes in two thirds and moderate or severe changes in one third. It involves the deep white matter symmetrically, tapering off toward the cortex. It is characterized by partial loss of myelin, axons, and oligodendroglial cells; mild reactive astrocytic gliosis; and sparsely distributed macrophages as well as stenosis resulting from hyaline fibrosis of arterioles and smaller vessels. No complete or cavitating infarctions and no hypertensive vascular changes were observed. The white matter changes are thought to be due to hypoperfusion of the concerned white matter territories since, in addition to the white matter hyaline vascular stenosis, these cases show signs of cardiovascular disease, usually with hypotension. The white matter disorder also occurs independent of the gray matter process of AD and SDAT and may be seen as the sole brain lesion in non‐AD subjects. Its occurrence is thus neither regularly related to the severity nor to the regional appearance and accentuation of the cortical Alzheimer process and is thus not likely to be just the result of a wallerian degeneration. Histologically it is similar in several respects to Binswanger's disease, although with some distinct differences. It is thus related to the cerebrovascular group of disorders in addition to AD and SDAT. In view of its frequency and severity, this white matter lesion is important to define, to diagnose, and ultimately to prevent or cure.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“White matter degeneration and microbleeds most likely reflect direct tissue damage,71,78–80”
In the citing paper
“white matter degeneration is related to Alzheimer disease pathology78”
In the citing paper
“white matter degeneration is related to Alzheimer disease pathology78 and microbleeds to CAA.”
In the citing paper
“In Alzheimer’s disease, white matter degeneration is a frequent structural brain change apart from grey matter atrophy (Brun and Englund, 1986).”
From White matter diffusion alterations precede symptom onset in autosomal dominant Alzheimer’s disease (2018) · cites this paper as Brun and Englund, 1986
In the citing paper
“Such white matter alterations cannot be fully accounted for as degenerative processes secondary to grey matter damage (Brun and Englund, 1986; Englund, 1998; Agosta et al., 2011), but may stem from vascular amyloid deposition and microvascular damage (Weller et al., 2009).”
From White matter diffusion alterations precede symptom onset in autosomal dominant Alzheimer’s disease (2018) · cites this paper as Brun and Englund, 1986
4 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Lipcsey, A. (1980) · PubMed · Cited by 1,083
Walton, J. N. (1976) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(76)90157-x · Cited by 964
Distribution and fatty acid composition of phosphoglycerides in normal human brain
Svennerholm, L. (1968) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)42702-6 · Cited by 639
Regional pattern of degeneration in Alzheimer's disease: neuronal loss and histopathological grading
BRUN, A., & ENGLUND, E. (1981) · Histopathology · doi:10.1111/j.1365-2559.1981.tb01818.x · Cited by 561
Self-citationDistribution of cerebral degeneration in Alzheimer's disease: A clinico-pathological study
Brun, A., & Gustafson, L. (1976) · Archiv f�r Psychiatrie und Nervenkrankheiten · doi:10.1007/bf00367450 · Cited by 397
Self-citationClinical features of subcortical arteriosclerotic encephalopathy (Binswanger disease)
Caplan, L. R., & Schoene, W. C. (1978) · Neurology · doi:10.1212/wnl.28.12.1206 · Cited by 282
Computed Tomography in the Elderly 2. Senile Dementia: Diagnosis and Functional Impairment
Jacoby, R. J., & Levy, R. (1980) · British Journal of Psychiatry · doi:10.1192/bjp.136.3.256 · Cited by 205
Goto, K., Ishii, N., & Fukasawa, H. (1981) · Radiology · doi:10.1148/radiology.141.3.7302224 · Cited by 181
OLSZEWSKI, J. (1962) · PubMed · Cited by 161
Subcortical arteriosclerotic encephalopathy: a clinical and radiological investigation.
Loizou, L. A., Kendall, B. E., & Marshall, J. (1981) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.44.4.294 · Cited by 139
Research works printed but not linked: 6
- Auff E, 1980, Contribution to the problem of presenile glial dystrophy, Neuropathology, 1, 113
- Binswanger O, 1984, Die Abgrenzung der allgemeinen progressiven Paralyse, Berl Klin Wochenschr, 31, 1103
- 1981, Editorial 1981.: Binswanger's encephalopathy, Lancet, 1, 923
- George AE, 1981, Parenchymal CT correlates of senile dementia (Alzheimer's disease): loss of grey‐white matter discriminability, AJNR, 2, 205
- Gustafson L, 1984, Proceedings of the VII World Congress of Psychiatry 1983
- Sternby NH, 1968, Atherosclerosis in a defined population, Acta Pathol Microbiol Scand Suppl, 194
Cited by
Items 501–600 of 1,000
Thal, D. R. (2009) · The Scientific World JOURNAL · doi:10.1100/tsw.2009.72 · Cited by 32
Zhou, C.-N., Chao, F.-L., Zhang, Y., Jiang, L., Zhang, L., Luo, Y.-M., Xiao, Q., Chen, L.-M., & Tang, Y. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00243 · Cited by 35
Diffusion tensor imaging zur Erfassung axonaler Degeneration bei Morbus Alzheimer
Stahl, R., Dietrich, O., Teipel, S. J., Hampel, H. J., Reiser, M. F., & Schoenberg, S. O. (2003) · Der Radiologe · doi:10.1007/s00117-003-0925-4 · Cited by 38
Skoog, I. (1997) · Archives of Neurology · doi:10.1001/archneur.1997.00550150029012 · Cited by 36
Magnetic Resonance Imaging and Histopathology in Dementia, Clinically of Frontotemporal Type
Larsson, E., Passant, U., Sundgren, P. C., Englund, E. M., Brun, A. E., Lindgren, A. G., & Gustafson, L. (2000) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000017225 · Cited by 38
Self-citationDiagnosis of Alzheimer's Disease
Reisberg, ., Burns, A. S., Brodaty, H., Eastwood, R., Rossor, M. N., Sartorius, N., & Winblad, B. G. (1997) · International Psychogeriatrics · doi:10.1017/s1041610297004675 · Cited by 38
Clinical Correlates of Alzheimer's Disease With and Without Silent Radiographic Abnormalities
Marder, K. S., Richards, M., Bello, J. A., Bell, K., Sano, M. C., Miller, L., Folstein, M., Albert, M., & Stern, Y. (1995) · Archives of Neurology · doi:10.1001/archneur.1995.00540260050015 · Cited by 38
Atrophy and dysfunction of parahippocampal white matter in mild Alzheimer's disease
Wang, C., Stebbins, G. T., Medina, D. A., Shah, R. C., Bammer, R., Moseley, M. E., & deToledo-Morrell, L. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.01.020 · Cited by 30
Patankar, T. F., Widjaja, E., Chant, H., McCollum, C. N., Baldwin, R., Jeffries, S., Sutcliffe, C., Burns, A. S., & Jackson, A. (2006) · European Journal of Neurology · doi:10.1111/j.1468-1331.2006.01115.x · Cited by 37
Yamada, K., Nagakane, Y., Sasajima, H., Nakagawa, M., Mineura, K., Masunami, T., Akazawa, K., & Nishimura, T. (2008) · American Journal of Neuroradiology · doi:10.3174/ajnr.a1028 · Cited by 38
Neuroimaging and Affective Disorder in Late Life: A Review
Morris, P., & Rapoport, S. I. (1990) · The Canadian Journal of Psychiatry · doi:10.1177/070674379003500415 · Cited by 35
Imaging small vessel-associated white matter changes in aging
Salat, D. H. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.11.041 · Cited by 36
Stricker, N. H., Salat, D. H., Foley, J. M., Zink, T. A., Kellison, I. L., McFarland, C. P., Grande, L. J., McGlinchey, R. E., Milberg, W., & Leritz, E. C. (2013) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617713000660 · Cited by 36
Sharp, F. R., DeCarli, C. S., Jin, L., & Zhan, X. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1096206 · Cited by 37
Serum cholesterol and variant in cholesterol-related gene CETP predict white matter microstructure
Warstadt, N. M., Dennis, E. L., Jahanshad, N., Kohannim, O., Nir, T. M., McMahon, K. L., de Zubicaray, G. I., Montgomery, G. W., Henders, A. K., Martin, N. G., et al. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.05.024 · Cited by 36
Li, L., Simoni, M., Küker, W., Schulz, U. G., Christie, S. N., Wilcock, G. K., & Rothwell, P. M. (2013) · Stroke · doi:10.1161/strokeaha.113.002775 · Cited by 36
Friese, U., Meindl, T., Herpertz, S. C., Reiser, M. F., Hampel, H. J., & Teipel, S. J. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-1386 · Cited by 37
Membrane cerebral lipids in Rett syndrome
Lekman, A. Y., Hagberg, B. A., & Svennerholm, L. T. (1991) · Pediatric Neurology · doi:10.1016/0887-8994(91)90082-v · Cited by 36
Anti-oxidants and cognitive function: a review of clinical and epidemiologic studies
Launer, L. J., & Kalmijn, S. (1998) · Journal of neural transmission. Supplementum · doi:10.1007/978-3-7091-6467-9_1 · Cited by 37
Edwards, N. C., Lao, P. J., Alshikho, M. J., Ericsson, O. M., Rizvi, B. M., Petersen, M. E., O’Bryant, S. E., Aguilar, L. F., Simoes, S., Mapstone, M. E., et al. (2024) · Brain Communications · doi:10.1093/braincomms/fcae331 · Cited by 35
Popescu, B. F. G., Robinson, C. A., Chapman, D., & Nichol, H. K. (2009) · The Cerebellum · doi:10.1007/s12311-009-0102-z · Cited by 35
Scheltens, P., Weinstein, H. C., & Leys, D. (1992) · Clinical Neurology and Neurosurgery · doi:10.1016/0303-8467(92)90175-3 · Cited by 35
AMPA receptors are the major mediators of excitotoxic death in mature oligodendrocytes
Leuchtmann, E. A., Ratner, A. E., Vijitruth, R., Qu, Y., & McDonald, J. W. (2003) · Neurobiology of Disease · doi:10.1016/j.nbd.2003.07.004 · Cited by 35
Miyamoto, E., Tomimoto, H., Nakao, S.-I., Wakita, H., Akiguchi, I., Miyamoto, K., & Shingu, K. (2001) · Stroke · doi:10.1161/hs1201.100216 · Cited by 35
Awad, I. A., Masaryk, T. J., & Magdinec, M. (1993) · Stroke · doi:10.1161/01.str.24.9.1339 · Cited by 35
Brunetti, A., Postiglione, A., Tedeschi, E., Ciarmiello, A., Quarantelli, M., Covelli, E. M., Milan, G., Larobina, M., Soricelli, A., Sodano, A., et al. (2000) · Journal of Magnetic Resonance Imaging · doi:10.1002/(sici)1522-2586(200003)11:3<260::aid-jmri4>3.0.co;2-i · Cited by 35
Amar, K. A., Bucks, R. S., Lewis, T., Scott, M., & Wilcock, G. K. (1996) · Age and Ageing · doi:10.1093/ageing/25.6.443 · Cited by 35
Detection of white matter lesion regions in MRI using SLIC0 and convolutional neural network
Diniz, P. H. B., Valente, T. L. A., Diniz, J. O. B., Silva, A. C., Gattass, M., Ventura, N., Muniz, B. C., & Gasparetto, E. L. (2018) · Computer Methods and Programs in Biomedicine · doi:10.1016/j.cmpb.2018.04.011 · Cited by 34
O'Dwyer, L., Lamberton, F., Matura, S., Scheibe, M., Miller, J., Rujescu, D., Prvulovic, D., & Hampel, H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036024 · Cited by 34
DNA Methylation Profiling Reveals the Change of Inflammation-Associated ZC3H12D in Leukoaraiosis
Huang, W.-Q., Yi, K.-H., Li, Z., Wang, H., Li, M., Cai, L., Lin, H.-N., Lin, Q., & Tzeng, C. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00143 · Cited by 34
Neuropathology, Neuroimaging, and Fluid Biomarkers in Alzheimer’s Disease
Colvee-Martin, H., Parra, J. R., Gonzalez, G. A., Barker, W., & Duara, R. (2024) · Diagnostics · doi:10.3390/diagnostics14070704 · Cited by 35
Wegrzyn, M., Teipel, S. J., Oltmann, I., Bauer, A. J., Thome, J., Großmann, A., Hauenstein, K., & Höppner, J. (2012) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2012.04.008 · Cited by 34
Hypertension, Cognitive Impairment and Dementia: An Epidemiological Perspective
Reitz, C., & Luchsinger, J. A. (2007) · Current Hypertension Reviews · doi:10.2174/157340207781386747 · Cited by 34
Nakata, Y., Sato, N., Abe, O., Shikakura, S., Arima, K., Furuta, N., Uno, M., Hirai, S., Masutani, Y., Ohtomo, K., et al. (2008) · Radiation Medicine · doi:10.1007/s11604-008-0258-3 · Cited by 34
Griffith, C. M., Xie, M.-X., Qiu, W., Sharp, A. A., Ma, C., Pan, A., Yan, X., & Patrylo, P. R. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2016.08.034 · Cited by 34
Tractography of the external capsule and cognition: A diffusion MRI study of cholinergic fibers
Nolze-Charron, G., Rouleau, R. D., Houde, J., Dumont, M., Castellano, C., Cunnane, S. C., Lorrain, D., Fülöp, T., Descoteaux, M., & Bocti, C. (2019) · Experimental Gerontology · doi:10.1016/j.exger.2019.110792 · Cited by 34
The Epidemiology of vascular dementia
Román, G. C. (2008) · Handbook of clinical neurology · doi:10.1016/s0072-9752(07)01259-6 · Cited by 34
Does APO epsilon 4 correlate with MRI changes in Alzheimer's disease?
Doody, R. S. (2000) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.69.5.668 · Cited by 30
Tian, J., Shi, J., Bailey, K. L., Harris, J. M., Pritchard, A. L., Lambert, J., Chartier‐Harlin, M., Pickering-Brown, S. M., Lendon, C. L., & Mann, D. M. A. (2003) · Neuroscience Letters · doi:10.1016/j.neulet.2003.09.072 · Cited by 34
VASCULAR DEMENTIA ITALIAN SULODEXIDE STUDY (VA.D.I.S.S.) CLINICAL AND BIOLOGICAL RESULTS
Parnetti, L., Mari, D., Abate, G., Balestreri, R., Cucinotta, D., Coppola, R., Cherubini, A., Ferrari, P., & Senin, U. (1997) · Thrombosis Research · doi:10.1016/s0049-3848(97)00122-9 · Cited by 34
van Es, A. C. G. M., van der Flier, W. M., Admiraal-Behloul, F., Olofsen, H., Bollen, E. L. E. M., Middelkoop, H. A. M., Weverling-Rijnsburger, A. W. E., Westendorp, R. G. J., & van Buchem, M. A. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.09.042 · Cited by 33
Kim, S. H., Kang, H. S., Kim, H. J., Moon, Y., Ryu, H. J., Kim, M. Y., & Han, S. (2012) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988712445089 · Cited by 33
Apolipoprotein D mRNA expression is elevated in PDAPP transgenic mice
Thomas, E. A., Sautkulis, L. N., Criado, J. R., Games, D., & Sutcliffe, J. G. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00654.x · Cited by 27
Neuropathological correlates to clinically defined dementia with Lewy bodies
Londos, E., Passant, U., Gustafson, L., & Brun, A. (2001) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.403 · Cited by 33
Self-citationLeukb‐Araiosis and Cerebral Hypoperfusion Compared in Elderly Normals and Alzheimer's Dementia
Kawamura, J., Meyer, J. S., Terayama, Y., & Weathers, S. (1992) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1992.tb02138.x · Cited by 33
Förster, C. Y., Shityakov, S., Scheper, V., & Lenarz, T. (2022) · Biomolecules · doi:10.3390/biom12111717 · Cited by 32
Liu, Z., Chao, J., Wang, C., Sun, G., Roeth, D., Liu, W., Chen, X., Li, L., Tian, E., Feng, L., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112841 · Cited by 31
Propionibacterium acnes in the cortex of patients with Alzheimer's disease
Kornhuber, H. H. (1996) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/bf02274902 · Cited by 32
Sun, X., Salat, D. H., Upchurch, K., Deason, R. G., Kowall, N. W., & Budson, A. E. (2014) · Journal of Investigative Medicine · doi:10.1097/jim.0000000000000102 · Cited by 33
Garcia-Ladona, F. J., Huss, Y., Frey, P., & Ghandour, M. S. (1997) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19971001)50:1<50::aid-jnr6>3.0.co;2-k · Cited by 32
Brain Imaging in Dementia of the Alzheimer Type
Faulstich, M. E. (1991) · International Journal of Neuroscience · doi:10.3109/00207459109150345 · Cited by 32
Caffrey, M. S., Braddock, D. T., Louis, J. M., Abu-Asab, M. S., Kingma, D. W., Liotta, L. A., Tsokos, M., Tresser, N. J., Pannell, L. K., Watts, N. R. M., et al. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m001036200 · Cited by 32
Plasma homocysteine and severe white matter disease
Censori, B., Partziguian, T., Manara, O., & Poloni, M. (2007) · Neurological Sciences · doi:10.1007/s10072-007-0832-y · Cited by 32
Regland, B., & Gottfries, C. G. (1992) · Medical Hypotheses · doi:10.1016/0306-9877(92)90153-4 · Cited by 32
de la Monte, S. M. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-230555 · Cited by 32
Lin, Q., Huang, W.-Q., & Tzeng, C. (2015) · Reviews in the Neurosciences · doi:10.1515/revneuro-2014-0082 · Cited by 31
Martyn, C. N. (1996) · The Lancet · doi:10.1016/s0140-6736(96)90603-0 · Cited by 31
Amyloid-beta induced retrograde axonal degeneration in a mouse tauopathy model
Nishioka, C., Liang, H.-F., Barsamian, B., & Sun, S.-W. (2019) · NeuroImage · doi:10.1016/j.neuroimage.2019.01.007 · Cited by 30
“Axonal damage and WM abnormalities in AD have been documented in numerous neuropathological studies (Shin et al., 1992; Umahara et al., 2002; Kowall and Kosik, 1987; Brun and Englund, 1986; Scheltens et al., 1995).”
Xekardaki, A., Giannakopoulos, P., & Haller, S. (2011) · Journal of Aging Research · doi:10.4061/2011/286564 · Cited by 30
Li, Y., Feng, F., Lin, P., Huang, Z., Liu, T., Zhou, B., Yao, H., Zheng, L., Li, C., Wang, P., et al. (2018) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2018.09.010 · Cited by 30
The identification of pathological subtypes of Alzheimer's disease using cluster analysis
Armstrong, R. A., & Wood, L. (1994) · Acta Neuropathologica · doi:10.1007/bf00294360 · Cited by 30
Masato, N., Hidekazu, M., Yukihisa, M., Kinzo, M., & Watanabe, H. (1998) · The Japanese Journal of Pharmacology · doi:10.1254/jjp.78.463 · Cited by 30
The apolipoprotein E gene in Binswanger's disease and vascular dementia
Higuchi, S., Arai, H., Nakagawa, T., Muramatsu, T., Sasaki, H., & Trojanowski, J. Q. (1996) · Clinical Genetics · doi:10.1111/j.1399-0004.1996.tb02712.x · Cited by 30
Gray‐matter degeneration in presenile alzheimer's disease
Prohovnik, I., Smith, G. S., Sackeïm, H. A., Mayeux, R. P., & Stern, Y. (1989) · Annals of Neurology · doi:10.1002/ana.410250203 · Cited by 30
A radiologic study of dynamic processes in lacunar dementia.
Tanaka, Y., Tanaka, O., Mizuno, Y., & Yoshida, M. (1989) · Stroke · doi:10.1161/01.str.20.11.1488 · Cited by 30
Zang, C., Liu, H., Ju, C., Yuan, F., Ning, J., Shang, M., Bao, X., Yu, Y., Yao, X., & Zhang, D. (2022) · Food & Function · doi:10.1039/d1fo02127c · Cited by 30
de la Monte, S. M., Tong, M., & Hapel, A. J. (2023) · Biomedicines · doi:10.3390/biomedicines11092394 · Cited by 30
Xing, Y., Wei, P., Wang, C., Shan, Y., Yu, Y., Qiao, Y., Xie, B., Shi, X., Zhu, Z., Lu, J., et al. (2020) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1002/trc2.12005 · Cited by 29
Yang, C., DeVisser, A., Martinez, J. A., Poliakov, I., Rosales-Hernandez, A., Ayer, A. B., Garven, A., Zaver, S., Rincon, N., Xu, K., et al. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.02.007 · Cited by 29
RetractedDrayer, B. P. (2005) · Cited by 29
Adachi, T., Takagi, M., Hoshino, H., & Inafuku, T. (1997) · Stroke · doi:10.1161/01.str.28.11.2174 · Cited by 29
Amar, K. A., Lewis, T., Wilcock, G. K., Scott, M., & Bucks, R. S. (1995) · Age and Ageing · doi:10.1093/ageing/24.5.411 · Cited by 29
Progressive subcortical gliosis of Neumann: a clinicopathologic study of two cases with review
Verity, M. A., & Wechsler, A. F. (1987) · Archives of Gerontology and Geriatrics · doi:10.1016/0167-4943(87)90025-2 · Cited by 29
Stone, D. B., Ryman, S. G., Hartman, A. P., Wertz, C. J., Vakhtin, A. A., & Initiative, A. D. N. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.711579 · Cited by 28
“…significant white matter (WM) degeneration, and increasing evidence suggests that WM changes appear early and independently of GM tissue loss, are associated with increased tau protein concentrations, and reflect cognitive decline (Amlien and Fjell, 2014; Brun and Englund, 1986; Gold et al., 2012).”
BackgroundLiu, Y., Liu, S., Tang, C., Tang, K., Liu, D., Chen, M., Mao, Z., & Xia, X. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.1068175 · Cited by 28
Cardiorespiratory fitness and white matter integrity in Alzheimer’s disease
Perea, R. D., Vidoni, E. D., Morris, J. K., Graves, R. S., Burns, J. M., & Honea, R. A. (2015) · Brain Imaging and Behavior · doi:10.1007/s11682-015-9431-3 · Cited by 28
Update on Diffusion Tensor Imaging in Alzheimer's Disease
Hess, C. P. (2009) · Magnetic Resonance Imaging Clinics of North America · doi:10.1016/j.mric.2009.02.003 · Cited by 28
Cerebral White Matter Lesions May Be Partially Reversible in Patients with Carotid Artery Stenosis
Yamada, K., Sakai, K., Owada, K., Mineura, K., & Nishimura, T. (2010) · American Journal of Neuroradiology · doi:10.3174/ajnr.a1873 · Cited by 28
Dementia associated with lacunar infarctions
Loeb, C., Gandolfo, C., Croce, R., & Conti, I. (1992) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/s1052-3057(10)80049-7 · Cited by 28
In vivo diffusion tensor imaging of amyloid‐β‐induced white matter damage in mice
Sun, S.-W., Liang, H.-F., Mei, J., Xu, D., & Shi, W.-X. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-130236 · Cited by 27
“AD is not usually considered a white matter disease, but recent evidence suggests a widespread white matter abnormality in patients with AD [1, 2].”
Postmortem MRI: a novel window into the neurobiology of late life cognitive decline
Dawe, R. J., Yu, L., Leurgans, S. E., Schneider, J. A., Buchman, A. S., Arfanakis, K., Bennett, D. A., & Boyle, P. A. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.05.023 · Cited by 26
Nonparenchymal fluid is the source of increased mean diffusivity in preclinical Alzheimer's disease
Sepehrband, F., Cabeen, R. P., Barisano, G., Sheikh‐Bahaei, N., Choupan, J., Law, M., Toga, A. W., & Initiative, A. D. N. (2019) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1016/j.dadm.2019.03.002 · Cited by 27
Armstrong, R. A. (2014) · BioMed Research International · doi:10.1155/2014/623487 · Cited by 27
Farkas, E., Annaházi, A., Institóris, Á., Mihály, A., Luiten, P. G. M., & Bari, F. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2004.10.007 · Cited by 27
White matter low attenuation on CT in Alzheimer's disease
Erkinjuntti, T., Sulkava, R. O., Palo, J., & Ketonen, L. (1989) · Archives of Gerontology and Geriatrics · doi:10.1016/0167-4943(89)90074-5 · Cited by 27
Progress in the genetics of cerebrovascular disease: inherited subcortical arteriopathies.
Bowler, J. V., & Hachinski, V. (1994) · Stroke · doi:10.1161/01.str.25.8.1696 · Cited by 27
Mental changes in subcortical arteriosclerotic encephalopathy
Derix, M. M. A., Hijdra, A., & Verbeeten, B., Jr. (1987) · Clinical Neurology and Neurosurgery · doi:10.1016/0303-8467(87)90179-x · Cited by 27
Bogucki, A., Papierz, W., Szymańska, R., & Staniaszczyk, R. (1988) · Journal of Neurology · doi:10.1007/bf00314490 · Cited by 27
Fornix degeneration in risk factors of Alzheimer's disease, possible trigger of cognitive decline
Lacalle‐Aurioles, M., & Iturria‐Medina, Y. (2023) · Cerebral Circulation - Cognition and Behavior · doi:10.1016/j.cccb.2023.100158 · Cited by 27
Opening of the Blood-Brain Barrier before Cerebral Pathology in Mild Hyperhomocysteinemia
Rhodehouse, B. C., Mayo, J. N., Beard, R. S., Chen, C.-H., & Bearden, S. E. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063951 · Cited by 26
Fascicle- and Glucose-Specific Deterioration in White Matter Energy Supply in Alzheimer’s Disease
Roy, M., Rheault, F., Croteau, É., Castellano, C., Fortier, M., St‐Pierre, V., Houde, J., Turcotte, É. E., Bocti, C., Fülöp, T., et al. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200213 · Cited by 26
Nilsson, K. H., Gustafson, L., & Hultberg, B. L. (2004) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.1140 · Cited by 26
Are vascular factors involved in Alzheimer’s disease? Facts and theories
Iorio, A. D., Zito, M., Lupinetti, M. C., & Abate, G. (1999) · Aging Clinical and Experimental Research · doi:10.1007/bf03339811 · Cited by 26
White Matter Alterations in Cognitively Normal apoE ɛ2 Carriers: Insight into Alzheimer Resistance?
Chiang, G. C., Zhan, W., Schuff, N., & Weiner, M. W. (2012) · American Journal of Neuroradiology · doi:10.3174/ajnr.a2984 · Cited by 25
Fixel-based analysis reveals tau-related white matter changes in early stages of Alzheimer's disease
Ahmadi, K., Pereira, J. B., Westen, D. V., Pasternak, O., Zhang, F., Nilsson, M., Stomrud, E., Spotorno, N., & Hansson, O. (2024) · The Journal of Neuroscience · doi:10.1523/jneurosci.0538-23.2024 · Cited by 25
White Matter Abnormalities in Two Different Subtypes of Amnestic Mild Cognitive Impairment
Liu, J., Liang, P., Yin, L., Shu, N., Zhao, T., Xing, Y., Li, F., Zhao, Z., Li, K., & Han, Y. (2017) · PLoS ONE · doi:10.1371/journal.pone.0170185 · Cited by 25
Vascular protective effects of KLF2 on Aβ-induced toxicity: Implications for Alzheimer’s disease
Fang, X., Zhong, X., Yu, G., Shao, S., & Yang, Q. (2017) · Brain Research · doi:10.1016/j.brainres.2017.01.006 · Cited by 26
White matter tauopathy: Transient functional loss and novel myelin remodeling
Jackson, J., Bianco, G., Rosa, A. O., Cowan, K., Bond, P., Anichtchik, O. V., & Fern, R. F. (2018) · Glia · doi:10.1002/glia.23286 · Cited by 25
Hypotension and cognitive impairment: Selective association in patients with heart failure
Sabatini, T., Barbisoni, P., Rozzini, R., & Trabucchi, M. (2002) · Neurology · doi:10.1212/wnl.59.7.1118-a · Cited by 25
Stricker, N. H., Salat, D. H., Kuhn, T. P., Foley, J. M., Price, J. S., Westlye, L. T., Esterman, M. S., McGlinchey, R. E., Milberg, W., & Leritz, E. C. (2015) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/1533317515578257 · Cited by 25
Metadata
- Authors
- Brun, A., & Englund, E.
- Affiliations
- Skåne University Hospital (SE)
- Corresponding author
- Brun, A.
- ORCID
- Englund, E.
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 1986-03
- Volume
- 19
- Issue
- 3
- Pages
- 253-262
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W2017159332
- Cited by
- 1,014
- References
- 34
- Citations by year
- 2026: 8 · 2025: 16 · 2024: 15 · 2023: 25 · 2022: 19 · 2021: 14 · 2020: 18 · 2019: 21 · 2018: 24 · 2017: 22 · 2016: 22 · 2015: 23 · 2014: 37 · 2013: 33 · 2012: 30
- FWCI
- 26.38
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Annals of Neurology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
- Health Sciences › Medicine › Clinical Neurology › Cerebrovascular and genetic disorders
- Keywords
- Alzheimer's disease, senile dementia of the Alzheimer type, white matter disease, deep white matter, demyelination, oligodendrocyte loss, astrocytic gliosis, cerebral hypoperfusion, cardiovascular disease, Binswanger disease, cerebrovascular disease, Wallerian degeneration
- MeSH terms
- Aged, Alzheimer Disease, Brain, Cardiovascular Diseases, Cerebral Infarction, Dementia, Humans, Middle Aged, Periaqueductal Gray, Severity of Illness Index
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.